Katsuyo Doi-Ohashi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Subcutaneous immunotherapy-induced IgG1 suppresses allergic airway inflammation through FcγRIIb-mediated inhibition of group 2 innate lymphoid cell proliferation.

Subcutaneous immunotherapy-induced IgG1 suppresses allergic airway inflammation through FcγRIIb-mediated inhibition of group 2 innate lymphoid cell proliferation.

Journal: The World Allergy Organization journal
Published: December 02, 2025

Enhancement of Immune Modulation by Toll-Like Receptor 9 Adjuvant Combination Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.

Enhancement of Immune Modulation by Toll-Like Receptor 9 Adjuvant Combination Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.

Journal: Biological & pharmaceutical bulletin
Published: August 12, 2025

Global variations of IgE cross-reactivity in Cupressus allergy.

Global variations of IgE cross-reactivity in Cupressus allergy.

Journal: The journal of allergy and clinical immunology. Global
Published: June 24, 2025

Delayed Upper Gastrointestinal Motility in Mice Treated with Oral Iron Tablets.

Delayed Upper Gastrointestinal Motility in Mice Treated with Oral Iron Tablets.

Journal: Biological & pharmaceutical bulletin
Published: April 23, 2025

Development of fast dissolving sublingual immunotherapy tablet enhancing medication accessibility

Development of fast dissolving sublingual immunotherapy tablet enhancing medication accessibility

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: January 05, 2025

Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis.

Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis.

Journal: Future science OA
Published: November 14, 2024

Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model.

Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model.

Journal: Scientific reports
Published: June 06, 2024

Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1-4 years old children with perennial allergic rhinitis.

Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1-4 years old children with perennial allergic rhinitis.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: March 20, 2024

Post-hoc safety/efficacy analyses from pediatric delgocitinib atopic dermatitis trials.

Post-hoc safety/efficacy analyses from pediatric delgocitinib atopic dermatitis trials.

Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: October 31, 2023

Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis.

Cha o 3, a cypress pollen allergen, does not activate basophils in Japanese cypress pollinosis.

Journal: The journal of allergy and clinical immunology. Global
Published: July 30, 2023

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets.

Journal: Current therapeutic research, clinical and experimental
Published: April 26, 2022

Japanese Cedar Pollen Allergens in Japan.

Japanese Cedar Pollen Allergens in Japan.

Journal: Current protein & peptide science
Published: February 26, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026